Literature DB >> 349156

Resolution of antimalarial agents via complex formation with alpha-(2,4,5,7-tetranitro-9-fluorenylideneaminooxy) propionic acid.

F I Carroll, B Berrang, C P Linn.   

Abstract

The resolution of several antimalarial agents via pi-complex formation with alpha-(2,4,5,7-tetranitro-9-fluorenylideneaminooxy) propionic acid (TAPA) is reported. Since this represents the first use of this agent for the resolution of amines, some details of the separations are presented. The method proved successful for resolving weakly alkaline amines that did not form stable salts with common resolving acids, highly insoluble amines that did not form soluble salts with usual resolving acids, and amines that did not form crystalline salts with commonly available resolving acids. The optical isomers of several antimalarial agents were evaluated against Plasmodium berghei in the mouse. None of the optically active forms showed any significant differences. The curative activity of (+)- and (-)-primaquine against Plasmodium cynomolgi in the rhesus monkey was essentially identical; however, significant differences in toxicity were noted.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 349156     DOI: 10.1021/jm00202a002

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  In vitro activity of the enantiomers of mefloquine, halofantrine and enpiroline against Plasmodium falciparum.

Authors:  L K Basco; C Gillotin; F Gimenez; R Farinotti; J Le Bras
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

2.  X-ray crystal structure of the antimalarial agent (-)-halofantrine hydrochloride supports stereospecificity for cardiotoxicity.

Authors:  J M Karle
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

3.  Synthesis, antimalarial, antileishmanial, antimicrobial, cytotoxicity, and methemoglobin (MetHB) formation activities of new 8-quinolinamines.

Authors:  Sanjay R Patel; Premanand Patil; Kirandeep Kaur; Meenakshi Jain; Shabana I Khan; Melissa R Jacob; Babu L Tekwani; Rahul Jain
Journal:  Bioorg Med Chem       Date:  2006-10-20       Impact factor: 3.641

4.  Novel sulfur-containing microbial metabolite of primaquine.

Authors:  C D Hufford; J K Baker; J D McChesney; A M Clark
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

Review 5.  Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potential.

Authors:  H M Bryson; K L Goa
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

6.  Scalable preparation and differential pharmacologic and toxicologic profiles of primaquine enantiomers.

Authors:  N P Dhammika Nanayakkara; Babu L Tekwani; H M T Bandara Herath; Rajnish Sahu; Montip Gettayacamin; Anchalee Tungtaeng; Yvonne van Gessel; Paul Baresel; Kristina S Wickham; Marilyn S Bartlett; Frank R Fronczek; Victor Melendez; Colin Ohrt; Gregory A Reichard; James D McChesney; Rosemary Rochford; Larry A Walker
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

Review 7.  Clinical pharmacokinetics of halofantrine.

Authors:  J Karbwang; K Na Bangchang
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.